Effect of Memantine on Cue-Induced Alcohol Craving in Recovering Alcohol-Dependent Patients
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Ethanol blocks N-methyl-d-aspartic acid (NMDA) glutamate receptors. Increased NMDA receptor function may contribute to motivational disturbances that contribute to alcoholism. The authors assessed whether the NMDA receptor antagonist memantine reduces cue-induced alcohol craving and produces ethanol-like subjective effects. METHOD: Thirty-eight alcohol-dependent inpatients participated in three daylong testing sessions in a randomized order under double-blind conditions. On each test day, subjects received 20 mg of memantine, 40 mg of memantine, or placebo, and subjective responses to treatment were assessed. The level of alcohol craving was assessed before and after exposure to an alcohol cue. RESULTS: Memantine did not stimulate alcohol craving before exposure to an alcohol cue, and it attenuated alcohol cue-induced craving in a dose-related fashion. It produced dose-related ethanol-like effects without adverse cognitive or behavioral effects. CONCLUSIONS: These data support further exploration of whether well-tolerated NMDA receptor antagonists might have a role in the treatment of alcoholism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The hopkins verbal learning test: Development of a new memory test with six equivalent forms
Brandt, J. (1991) · Clinical Neuropsychologist · doi:10.1080/13854049108403297 · Cited by 1,317
Cited by
Glutamatergic substrates of drug addiction and alcoholism
Gass, J. T., & Olive, M. F. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.039 · Cited by 484
Leeman, R. F., & Potenza, M. N. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2550-7 · Cited by 448
Why gamblers fail to win: A review of cognitive and neuroimaging findings in pathological gambling
van Holst, R. J., van den Brink, W., Veltman, D. J., & Goudriaan, A. E. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.07.007 · Cited by 372
Sani, G., Serra, G., Kotzalidis, G. D., Romano, S., Tamorri, S. M., Manfredi, G., Caloro, M., Telesforo, C. L., Caltagirone, S. S., Panaccione, I., et al. (2012) · CNS Drugs · doi:10.2165/11634390-000000000-00000 · Cited by 273
Update on neuropharmacological treatments for alcoholism: Scientific basis and clinical findings
Johnson, B. A. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.005 · Cited by 264
Ketamine and rapid antidepressant action: New treatments and novel synaptic signaling mechanisms
Krystal, J. H., Kavalali, E. T., & Monteggia, L. M. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-023-01629-w · Cited by 262
“It should be noted, however, that a 40 mg dose of memantine [93], twice the dose of memantine used in the depression trial, still produces subjective effects (euphoria, stimulation, sedation, etc.) that are similar but quite less intense than a standard antidepressant dose of ketamine [94].”
BackgroundSelf-citationGlutamatergic medications for the treatment of drug and behavioral addictions
Olive, M. F., Cleva, R. M., Kalivas, P. W., & Malcolm, R. J. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.04.015 · Cited by 210
“In addition to being efficacious at reducing withdrawal symptoms in detoxifying alcoholics (Krupitsky et al., 2007b) and opiate addicts (Bisaga et al., 2001), memantine (typical doses in the 30–60 mg/day range) has been reported to be superior to placebo in attenuating on-going drinking and/or…”
BackgroundInfluentialGlutamatergic targets for new alcohol medications
Holmes, A., Spanagel, R., & Krystal, J. H. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3226-2 · Cited by 197
“In alcohol-dependent patients, memantine has been found to reduce withdrawal (Krupitsky et al. 2007b) and cue-induced alcohol craving (Krupitsky et al. 2007a), and to reduce alcohol consumption in moderate drinkers (Bisaga and Evans 2004).”
InfluentialSelf-citationWills, T. A., Klug, J. R., Silberman, Y., Baucum, A. J., Weitlauf, C., Colbran, R. J., Delpire, E., & Winder, D. G. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113820109 · Cited by 98
“Interestingly, it has been shown to reduce reports of withdrawal severity (79).”
BackgroundThe neurobiological reward system in Prolonged Grief Disorder (PGD): A systematic review
Kakarala, S. E., Roberts, K. E., Rogers, M., Coats, T., Falzarano, F., Gang, J., Chilov, M., Avery, J., Maciejewski, P. K., Lichtenthal, W. G., et al. (2020) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2020.111135 · Cited by 85
Pharmacological approaches to reducing craving in patients with alcohol use disorders
Haass-Koffler, C. L., Leggio, L., & Kenna, G. A. (2014) · CNS Drugs · doi:10.1007/s40263-014-0149-3 · Cited by 83
“been investigated in alcohol-dependent patients [213].”
D-Serine and D-Cycloserine Reduce Compulsive Alcohol Intake in Rats
Seif, T., Simms, J. A., Lei, K., Wegner, S., Bonci, A., Messing, R. O., & Hopf, F. W. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.84 · Cited by 75
“Memantine, a noncompetitive NMDAR antagonist, has shown promise in some studies (Bisaga and Evans, 2004; Krupitsky et al, 2007; Muhonen et al, 2008) but not others (Evans et al, 2007).”
BackgroundAlcohol and violence: neuropeptidergic modulation of monoamine systems
Miczek, K. A., DeBold, J. F., Hwa, L. S., Newman, E. L., & de Almeida, R. M. M. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12862 · Cited by 67
NMDA receptor antagonism: escalation of aggressive behavior in alcohol-drinking mice
Newman, E. L., Chu, A., Bahamón, B., Takahashi, A., DeBold, J. F., & Miczek, K. A. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2734-9 · Cited by 46
Hwa, L., Besheer, J., & Kash, T. (2017) · F1000Research · doi:10.12688/f1000research.9609.1 · Cited by 39
Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review
Fischler, P. V., Soyka, M., Seifritz, E., & Mutschler, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.927703 · Cited by 34
“, 2015), in a randomized, double-blind, placebo-controlled clinical study comparing memantine 20 mg/d and 40 mg/d against placebo, a significant alcohol cue-induced craving reduction was evident, but no effect on craving was found prior to alcohol-cue stimulus under memantine treatment (Krupitsky et al., 2007).”
Background
Metadata
- Authors
- Krupitsky, E. M., Neznanova, O., Masalov, D., Burakov, A. M., Didenko, T., Romanova, T., Tsoy, M., Bespalov, A., Slavina, T. Y., Grinenko, A. A., Petrakis, I. L., Pittman, B., Gueorguieva, R., Zvartau, E. E., & Krystal, J. H.
- Venue
- American Journal of Psychiatry
- Published
- 2007-03
- Volume
- 164
- Issue
- 3
- Pages
- 519-523
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2160630552
- Cited by
- 116
- References
- 1
- FWCI
- 7.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.